Patents by Inventor Lars Lehmann Hylling Christensen

Lars Lehmann Hylling Christensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mashing Process
    Publication number: 20140170712
    Abstract: The present invention relates to a mashing and filtration step in a brewing process and to a composition useful in the mashing and filtration step of a brewing process.
    Type: Application
    Filed: February 27, 2014
    Publication date: June 19, 2014
    Applicant: Novozymes A/S
    Inventors: Rikke Monica Festersen, Anders Viksoe Nielsen, Christel Thea Joergensen, Lars Lehmann Hylling Christensen
  • Mashing process
    Patent number: 8679791
    Abstract: The present invention relates to a mashing and filtration step in a brewing process and to a composition useful in the mashing and filtration step of a brewing process.
    Type: Grant
    Filed: June 29, 2009
    Date of Patent: March 25, 2014
    Assignee: Novozymes A/S
    Inventors: Rikke Monica Festersen, Anders Viksoe Nielsen, Christel Thea Joergensen, Lars Lehmann Hylling Christensen
  • Protease variants
    Patent number: 8377677
    Abstract: The invention relates to a novel 3D structure encoding a Nocardiopsis protease, as well as to variants of parent protease homologous to Nocardiopsis proteases, preferably of improved thermostability and/or with an amended temperature activity profile. The invention also relates to DNA sequences encoding such variants, their production in a recombinant host cell, as well as methods of using the variants, in particular within the field of animal feed and detergents. The invention furthermore relates to methods of generating and preparing protease variants of amended properties.
    Type: Grant
    Filed: January 5, 2011
    Date of Patent: February 19, 2013
    Assignee: Novozymes A/S
    Inventors: Leonardo De Maria, Carsten Andersen, Lars Lehmann Hylling Christensen, Soren Flensted Lassen, Peter Rahbek Ostergaard
  • Galactanase variants
    Patent number: 8367390
    Abstract: The present invention relates to variants of Glycoside Hydrolase family 53 galactanases, e.g., variants of the galactanases from strains of Yersinia, Aspergillus, Humicola, Meripilus, Myceliophthora, Thermomyces, Bacillus, Bifidobacterium, Cellvibrio, Clostridium, Pseudomonas, Thermotoga, or Xanthomonas.
    Type: Grant
    Filed: April 8, 2009
    Date of Patent: February 5, 2013
    Assignee: Novozymes A/S
    Inventors: Leonardo De Maria, Allan Svendsen, Torben Vedel Borchert, Lars Lehmann Hylling Christensen, Sine Larsen, Carsten Ryttersgaard
  • Lipase Variants for Pharmaceutical Use
    Publication number: 20120308543
    Abstract: The pharmaceutical use of lipases related to the Thermomyces lanuginosus (Humicola lanuginosa) lipase comprising amino acids 1-269 of SEQ ID NO: 2, optionally in combination with a protease and/or an amylase. Examples of medical indications are: Treatment of digestive disorders, pancreatic exocrine insufficiency (PEI), pancreatitis, cystic fibrosis, diabetes type I, and/or diabetes type II. The lipases of the invention have, e.g., an improved digestion performance in vitro, an improved activity at a pH in the neutral range, an improved stability at low pH, an are stable against protease-degradation, and/or are stable in the presence of pepsin and bile salts. The invention also relates to methods of determining digestion performance in vitro of lipases, as well as to certain novel variants of the lipase of T. lanuginosus.
    Type: Application
    Filed: August 16, 2012
    Publication date: December 6, 2012
    Applicants: NOVOZYMES, INC., NOVOZYMES A/S
    Inventors: Allan Svendsen, Michael Skjoet, Deborah Yaver, Lars Lehmann Hylling Christensen, Signe Eskildsen Larsen, Nina Lundin, Michael Lamsa, Peter Colin Gregory
  • Lipase variants for pharmaceutical use
    Patent number: 8273348
    Abstract: The pharmaceutical use of lipases related to the Thermomyces lanuginosus (Humicola lanuginosa) lipase comprising amino acids 1-269 of SEQ ID NO: 2, optionally in combination with a protease and/or an amylase. Examples of medical indications are: Treatment of digestive disorders, pancreatic exocrine insufficiency (PEI), pancreatitis, cystic fibrosis, diabetes type I, and/or diabetes type II. The lipases of the invention have, e.g., an improved digestion performance in vitro, an improved activity at a pH in the neutral range, an improved stability at low pH, an are stable against protease-degradation, and/or are stable in the presence of pepsin and bile salts. The invention also relates to methods of determining digestion performance in vitro of lipases, as well as to certain novel variants of the lipase of T. lanuginosus.
    Type: Grant
    Filed: December 12, 2007
    Date of Patent: September 25, 2012
    Assignees: Novozymes A/S, Novozymes Inc.
    Inventors: Allan Svendsen, Michael Skjoet, Debbie Yaver, Lars Lehmann Hylling Christensen, Signe Eskildsen Larsen, Nina Lundin, Michael Lamsa, Peter Colin Gregory
  • FAMILY GH 61 POLYPEPTIDES
    Publication number: 20120009300
    Abstract: The present invention relates to use of an anti-staling GH-61 polypeptide for preparing an edible product.
    Type: Application
    Filed: September 23, 2011
    Publication date: January 12, 2012
    Applicant: Novozymes A/S
    Inventors: Kirk Matthew Schnorr, Sara Landvik, Tina Spendler, Lars Lehmann Hylling Christensen
  • PROTEASE VARIANTS
    Publication number: 20110097445
    Abstract: The invention relates to a novel 3D structure encoding a Nocardiopsis protease, as well as to variants of parent protease homologous to Nocardiopsis proteases, preferably of improved thermostability and/or with an amended temperature activity profile. The invention also relates to DNA sequences encoding such variants, their production in a recombinant host cell, as well as methods of using the variants, in particular within the field of animal feed and detergents. The invention furthermore relates to methods of generating and preparing protease variants of amended properties.
    Type: Application
    Filed: January 5, 2011
    Publication date: April 28, 2011
    Applicant: Novozymes A/S
    Inventors: Leonardo De Maria, Carsten Andersen, Lars Lehmann Hylling Christensen, Søren Flensted Lassen, Peter Rahbek Østergaard
  • Protease variants
    Patent number: 7892808
    Abstract: The invention relates to a novel 3D structure determined for a Nocardiopsis protease, as well as to variants of parent protease homologous to Nocardiopsis proteases, preferably of improved thermostability and/or with an altered temperature activity profile. The invention also relates to DNA sequences encoding such variants, their production in a recombinant host cell, as well as methods of using the variants, in particular within the field of animal feed and detergents. The invention further relates to methods of generating and preparing protease variants having different properties.
    Type: Grant
    Filed: October 8, 2004
    Date of Patent: February 22, 2011
    Assignee: Norozymes A/S
    Inventors: Leonardo De Maria, Carsten Andersen, Lars Lehmann Hylling Christensen, Soren Flensted Lassen, Peter Rahbek Ostergaard
  • Family GH 61 polypeptides
    Patent number: 7803590
    Abstract: The present invention relates to use of an anti-staling GH-61 polypeptide for preparing an edible product.
    Type: Grant
    Filed: November 12, 2009
    Date of Patent: September 28, 2010
    Assignee: Novozymes A/S
    Inventors: Kirk Matthew Schnorr, Sara Landvik, Tina Spendler, Lars Lehmann Hylling Christensen
  • FAMILY GH 61 POLYPEPTIDES
    Publication number: 20100093592
    Abstract: The present invention relates to use of an anti-staling GH-61 polypeptide for preparing an edible product.
    Type: Application
    Filed: November 12, 2009
    Publication date: April 15, 2010
    Applicant: Novozymes A/S
    Inventors: Kirk Matthew Schnorr, Sara Landvik, Tina Spendler, Lars Lehmann Hylling Christensen
  • Mashing Process
    Publication number: 20090269818
    Abstract: The present invention relates to a mashing and filtration step in a brewing process and to a composition useful in the mashing and filtration step of a brewing process.
    Type: Application
    Filed: June 29, 2009
    Publication date: October 29, 2009
    Applicant: Novozymes A/S
    Inventors: Rikke Monika Festersen, Anders Viksoe Nielsen, Christel Thea Joergensen, Lars Lehmann Hylling Christensen
  • GALACTANASE VARIANTS
    Publication number: 20090203106
    Abstract: The present invention relates to variants of Glycoside Hydrolase family 53 galactanases, e.g., variants of the galactanases from strains of Yersinia, Aspergillus, Humicola, Meripilus, Myceliophthora, Thermomyces, Bacillus, Bifidobacterium, Cellvibrio, Clostridium, Pseudomonas, Thermotoga, or Xanthomonas.
    Type: Application
    Filed: April 8, 2009
    Publication date: August 13, 2009
    Applicant: Novozymes A/S
    Inventors: Leonardo De Maria, Allan Svendsen, Torben Vedel Borchert, Lars Lehmann Hylling Christensen, Carsten Ryttergaard, Sine Larsen
  • Galactanase variants
    Patent number: 7537921
    Abstract: Variants of Glycoside Hydrolase family 53 galactanases, e.g. variants of the galactanases from strains of Yersinia, Aspergillus, Humicola, Meripilus, Myceliophthora, Thermomyces, Bacillus, Bifidobacterium, Cellvibrio, Clostridium, Pseudomonas, Thermotoga, or Xanthomonas.
    Type: Grant
    Filed: December 11, 2003
    Date of Patent: May 26, 2009
    Assignee: Novozymes A/S
    Inventors: Leonardo De Maria, Allan Svendsen, Torben Vedel Borchert, Lars Lehmann Hylling Christensen, Sine Larsen, Carsten Ryttersgaard
  • Protease variants
    Publication number: 20090047387
    Abstract: The invention relates to a novel 3D structure encoding a Nocardiopsis protease, as well as to variants of parent protease homologous to Nocardiopsis proteases, preferably of improved thermostability and/or with an amended temperature activity profile. The invention also relates to DNA sequences encoding such variants, their production in a recombinant host cell, as well as methods of using the variants, in particular within the field of animal feed and detergents. The invention furthermore relates to methods of generating and preparing protease variants of amended properties.
    Type: Application
    Filed: October 8, 2004
    Publication date: February 19, 2009
    Applicant: Novozymes A/S
    Inventors: Leonardo De Maria, Carsten Andersen, Lars Lehmann Hylling Christensen, Soren Flensted Lassen, Peter Rahbek Ostergaard
  • Family GH-61 polypeptides
    Patent number: 7273738
    Abstract: The present invention relates to use of an anti-staling GH-61 polypeptide for preparing an edible product.
    Type: Grant
    Filed: October 1, 2003
    Date of Patent: September 25, 2007
    Assignee: Novozymes A/S
    Inventors: Kirk Matthew Schnorr, Sara Landvik, Tina Spendler, Lars Lehmann Hylling Christensen
  • Family GH 61 polypeptides
    Publication number: 20040180420
    Abstract: The present invention relates to use of an anti-staling GH-61 polypeptide for preparing an edible product.
    Type: Application
    Filed: October 1, 2003
    Publication date: September 16, 2004
    Applicant: Novozymes A/S
    Inventors: Kirk Matthew Schnorr, Sara Landvik, Tina Spendler, Lars Lehmann Hylling Christensen